Stocks
Assessing Goldman Shares: A 26.8% YTD Increase – Hold or Sell?
“`html Goldman Sachs Group, Inc. (GS) shares have increased 26.8% year-to-date as of mid-2025, outpacing the financial industry’s 22.2% growth. In comparison, JPMorgan (JPM) ...
Should You Consider Cisco Systems Stock Ahead of Q4 Earnings?
“`html Cisco Systems (CSCO) is set to report its fiscal fourth quarter results after market hours on Wednesday, August 13, with sales expected to ...
SoundHound AI Sees Record Quarter: Is Now the Time to Invest?
“`html SoundHound AI, Inc. (SOUN) experienced a 31.7% decline in stock value this year due to increasing competition from Chinese AI firm DeepSeek and ...
Analyzing Archer Aviation Stock: Investment Strategy Ahead of Q2 Earnings
Archer Aviation Inc. (ACHR) shares have increased by 169.2% over the past year, outpacing the Aerospace – Defense industry, which saw a 16.1% rise. ...
Analyzing Amazon’s Q3 Operating Income Forecast: Is It Time to Hold or Sell?
“`html Amazon reported second-quarter revenues of $167.7 billion, exceeding the Zacks Consensus Estimate by 3.32%. Earnings per share of $1.68 also surpassed expectations by ...
Two Promising High-Growth Stocks to Consider: ADRNY and KALU
Ahold and Kaiser Aluminum are identified as emerging high-growth stocks with appealing valuations, trading under 16X forward earnings and 0.3X forward sales. Ahold, a ...
Evaluating CVS: Strong Q2 Performance, Attractive Valuation, and Promising Long-Term Prospects
CVS Health reported second-quarter earnings for 2025 on July 31, showing total revenues of $98.9 billion, an increase of 8.4% year over year. The ...
Analyzing BigBear.ai: Investment Strategies Ahead of Q2 Earnings
“`html BigBear.ai Holdings, Inc. (BBAI) is set to report its second-quarter 2025 results on August 11, after the market closes. Last quarter, the company ...
UBER Reports Strong Q2 Earnings and Revenue Growth Exceeding Expectations
Uber Technologies, Inc. reported second-quarter earnings on August 6, 2025, with earnings per share at 63 cents, exceeding the Zacks Consensus Estimate by one ...
Bio-Techne Reports Strong Q4 Earnings Despite Lower Gross Margins and Stock Decline
Bio-Techne (TECH) reported adjusted earnings per share (EPS) of 53 cents for the fourth quarter of fiscal 2025, exceeding the Zacks Consensus Estimate by ...
